Firdapse: “Now Approved” Page




Brand: Firdapse (amifampridine), Tablets
Parent Company: Catalyst Pharmaceuticals
Drug Type: Prescription
Drug Category: Immunology
Campaign: now-approved
Targeting: HCPs, Patients
Patient Website: https://www.firdapse.com/
HCP Website: